» Articles » PMID: 28131544

Evidence-Based Indications for Mobile-Bearing Unicompartmental Knee Arthroplasty in a Consecutive Cohort of Thousand Knees

Overview
Journal J Arthroplasty
Specialty Orthopedics
Date 2017 Jan 30
PMID 28131544
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The indications for unicompartmental knee arthroplasty remain controversial. Previously recommended contraindications include the following: age under 60 years, weight 180 lb (82 kg) or over, patients undertaking heavy labor, chondrocalcinosis, and exposed bone in the patellofemoral joint. This study explores whether these contraindications are valid in mobile-bearing unicompartmental knee arthroplasty.

Methods: Using a prospective series of 1000 consecutive medial unicompartmental knee arthroplasties in which the reported contraindications were not applied, the functional outcome and survival in patients with or without contraindications were compared.

Results: Of the 1000 consecutive unicompartmental knee arthroplasties (818 patients), 68% (678 knees) would be considered contraindicated based on published contraindications. At a mean follow-up of 10 years (5-17), there was no difference in American Knee Society (AKS) Objective Scores (P = .05) or Oxford Knee Score (P = .08) between groups. However, knees with contraindications had significantly (P = .02) fewer poor outcomes and significantly better AKS Functional Scores (P < .001) and Tegner Activity Scores (P < .001). At 15 years, no difference in implant survival (P = .33) was observed. The 3% of unicompartmental knee arthroplasties performed in young men (age <60) weighing 180 lb or over with high activity levels, who have been reported to have poor outcomes after fixed-bearing unicompartmental knee arthroplasty, had significantly better AKS Functional Scores (P < .001), Oxford Knee Score (P = .01), and Tegner Activity Score (P < .001) at 10 years. No difference in AKS Objective Scores (P = .54) at 10 years or implant survival at 15 years (P = .75) was seen.

Conclusion: This large case series provides evidence that patients with the previously reported contraindications do as well as, or even better than, those without contraindications. Therefore these contraindications should not apply to mobile-bearing unicompartmental knee arthroplasty.

Citing Articles

Association of patellofemoral osteoarthritis on patient-reported outcomes after medial unicompartmental knee arthroplasty: a retrospective cohort study.

Olsen J, Bredgaard Jensen C, Bunyoz K, Bagge A, Gromov K, Troelsen A Acta Orthop. 2025; 96():19-25.

PMID: 39786204 PMC: 11714781. DOI: 10.2340/17453674.2024.42575.


The impact of patellofemoral joint diseases on functional outcomes and prosthesis survival in patients undergoing unicompartmental knee arthroplasty: a systematic review and meta-analysis.

Yang J, Li X, Liu P, Liu X, Li L, Zhang M J Orthop Surg Res. 2024; 19(1):840.

PMID: 39696549 PMC: 11656892. DOI: 10.1186/s13018-024-05273-y.


Opening wedge high tibial osteotomy yields comparable to superior outcomes to unicompartmental knee arthroplasty at 2 years of follow-up in patients suffering from Ahlbäck III knee osteoarthritis: A propensity score-matched analysis.

Onishi S, Jacquet C, Nakayama H, Argenson J, Ollivier M J Exp Orthop. 2024; 11(4):e70105.

PMID: 39624640 PMC: 11609990. DOI: 10.1002/jeo2.70105.


Comparison of early curative effects of lateral unicompartmental knee arthroplasty with total knee arthroplasty and the legacy constrained condylar knee arthroplasty in the treatment of isolated lateral osteoarthritis: a single-center retrospective....

Yu H, Meng J, Xu Y, Xu K, Lin C, Bao J J Orthop Surg Res. 2024; 19(1):597.

PMID: 39342362 PMC: 11438380. DOI: 10.1186/s13018-024-05076-1.


All-Polyethylene Tibial Component in Unicompartmental Knee Arthroplasty Offers Excellent Survivorship and Clinical Outcomes at Short-Term Follow-Up: A Multicenter Retrospective Clinical Study.

Bonanzinga T, Adravanti F, Vitale U, Anzillotti G, Iacono F, Marcacci M Medicina (Kaunas). 2024; 60(9).

PMID: 39336492 PMC: 11434418. DOI: 10.3390/medicina60091451.